| abstract |
A compound having 5-HT receptor antagonistic activity and useful for eating disorders such as psychosis, neurological disease, amyotrophic lateral sclerosis, bulimia, anorexia, premenstrual syndrome, obsessive compulsive neurosis, And providing a pharmaceutical composition containing the compound. A compound of formula I and a pharmaceutical composition containing the compound. (Wherein X is N or CH, R 1 is H, A, Hal or the like, R 2 is cycloalkyl having 3 to 7 carbon atoms, trifluoromethyl or the like; 3 and R 4 are H or the like, and A is linear or branched alkyl or alkoxy having 1 to 10 carbon atoms, alkenyl or alkoxyalkyl having 2 to 10 carbon atoms, is there.) [Selection figure] None |